Business
Schrödinger to Present at Jefferies Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global
About this update from Schrodinger, Inc.
[{"type":"text","content":" NEW YORK--(BUSINESS WIRE)--\nSchrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T.\n\nThe live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.\n\nAbout Schrödinger\n\nSchrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250521380238/en/\n\nAllie Nicodemo\nSchrödinger, Inc.\[email protected]\n617-356-2325\n\nSource: Schrödinger","length":3385,"tagName":"div"}]